A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Boryung Pharmaceutical Co., Ltd.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
The Catholic University of Korea
Konyang University Hospital
Korea University
Ilsan Hospital
Daegu Fatima Hospital
Dong-A University
Soon Chun Hyang University
Asan Medical Center
Gangnam Severance Hospital
Severance Hospital
Ulsan University Hospital
Eulji University Hospital
Kangbuk Samsung Hospital
Sejong General Hospital
Ewha Womans University Mokdong Hospital
Jeju National University Hospital
Hallym University Medical Center
Hanyang University
Information provided by (Responsible Party):
Boryung Pharmaceutical Co., Ltd
ClinicalTrials.gov Identifier:
NCT01672476
First received: August 20, 2012
Last updated: September 4, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)